Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Monsanto Company (MON), Comcast Corporation (CMCSA) And Rockwood Holdings Inc. (ROC) Are Larry Foley And Paul Farrell’s Top Stock Pics

Founded in 2009 amid fears the financial world was about to crumble, Bronson Point Partners boasts a 58.5% return since then. The fund was founded and is run by Larry Foley and Paul Farrell, former employees of SAC Capital and Pequot respectively. They use fundamental analysis to identify investment opportunities in equity markets and employ a long and short equity strategy. In their latest Investor Letter, Foley and Farrell have announced a 3.4% return for the first 6 months of 2014, underperforming the S&P 500 index. However, it is worth noting that Bronson Point Partners return is based on an average of 43% net invested positions (S&P 500 is assumed to be 100% long). According to its latest 13F filing, the fund’s equity portfolio has an estimated market value of approximately $1.94 billion and is mainly invested in consumer discretionary, financial and energy stocks. Foley and Farrell have made some notable changes to their equity portfolios during the second quarter, therefore the fund’s top 3 positions will be analyzed in this article.

genetically modified foods

Top dog

Monsanto Company (NYSE:MON) is Larry Foley and Paul Farrell’s new favorite stock. During the second quarter they have built a new position that amasses 925,000 shares, worth in excess of $115 million. Larry Robbins of Glenview Capital is also a big fan of Monsanto Company (NYSE:MON) and has increased his fund’s investment in the company by 15% during the same period of time. Glenview Capital reportedly holds 8.4 million share valued at $1.05 billion. Andreas Halvorsen has boosted his investment in Monsanto Company (NYSE:MON) by 87%, taking it to 5.78 million shares worth in excess of $721 million.

After they have massively increased their exposure to Comcast Corporation (NASDAQ:CMCSA) during the first quarter, Foley and Farrell have started offloading shares during the second quarter, reducing their stake by 14%. In its latest 13F filing, Bronson Point Partners has reported ownership of 1.55 million shares valued at $83.5 million. Paul Ruddock And Steve Heinz, on the other hand, are still optimistic about the prospects of Comcast Corporation (NASDAQ:CMCSA) having upped their stake in the company by 2% during Q2. Their fund, Lansdowne Partners, reportedly holds 27.1 million shares valued at $1.45 billion. Jean-Marie Eveillard, the manager of First Eagle Investment Management, has also boosted his fund’s holding of Comcast Corporation (NASDAQ:CMCSA), taking it to 22.9 million shares worth $1.22 billion.

Foley and Farrell are positive Rockwood Holdings, Inc. (NYSE:ROC) still has room to grow and have further increased their investment in the company. Bronson Point Partners reportedly holds a little over 1 million shares, up 15% during the quarter, worth approximately $76.3 million. Jeffrey Gates is also bullish on Rockwood Holdings, Inc. (NYSE:ROC) and has upped his investment in the company by 22% during the second quarter. His fund, Gates Capital Management, holds 3.06 million shares worth $232 million according to its latest 13F filing. David E. Shaw, on the other hand, is not so optimistic and has chosen to reduce his fund’s exposure to Rockwood Holdings, Inc. (NYSE:ROC). His fund reportedly holds 1.2 million shares, down 18% during the quarter, valued at $91.7 million.

Disclosure: none.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!